Legend:
no star : Special Mention |  : Important | : Very Important | : Key Development |
| |
 |
Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese.
Hishida A, Matsuo K, Goto Y, Mitsuda Y, Hiraki A, Naito M, Wakai K, Tajima K, Hamajima N, Helicobacter. 2009 Feb;14(1):47-53 |
| |
Growth inhibitory action of cranberry on Helicobacter pylori.
Matsushima M, Suzuki T, Masui A, Kasai K, Kouchi T, Takagi A, Shirai T, Mine T, J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S175-80 |
| |
Prevalence of Helicobacter pylori infection and identification of risk factors in rural and urban Beijing, China.
Cheng H, Hu F, Zhang L, Yang G, Ma J, Hu J, Wang W, Gao W, Dong X, Helicobacter. 2009 Apr;14(2):128-33 |
| |
Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
Hung KH, Sheu BS, Chang WL, Wu HM, Liu CC, Wu JJ, Helicobacter. 2009 Feb;14(1):61-5 |
| |
Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran.
Nouraie M, Latifi-Navid S, Rezvan H, Radmard AR, Maghsudlu M, Zaer-Rezaii H, Amini S, Siavoshi F, Malekzadeh R, Helicobacter. 2009 Feb;14(1):40-6 |
| |
Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens.
Woo HY, Park DI, Park H, Kim MK, Kim DH, Kim IS, Kim YJ, Helicobacter. 2009 Feb;14(1):22-8 |
| |
Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
Nguyen TV, Bengtsson C, Nguyen GK, Hoang TT, Phung DC, Sörberg M, Granström M, Helicobacter. 2008 Dec;13(6):550-6 |
| |
Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Kim N, Park SH, Seo GS, Lee SW, Kim JW, Lee KJ, Shin WC, Kim TN, Park MI, Park JJ, Hong SJ, Shim KN, Kim SW, Shin YW, Chang YW, Chun HJ, Lee OJ, Jeon WJ, Park CG, Cho CM, Park CH, Won SY, Lee GH, Park KS, Shin JE, Kim HU, Park JY, Chae HS, Song GA, Kim JG, Yoon BC, Seol S, Jung HC, Chung IS, Helicobacter. 2008 Dec;13(6):542-9 |
| |
Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
Kawai T, Yamagishi T, Yagi K, Kataoka M, Kawakami K, Sofuni A, Itoi T, Sakai Y, Moriyasu F, Osaka Y, Takagi Y, Aoki T, Rimbara E, Noguchi N, Sasatsu M, J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S171-4 |
| |
Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population.
Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, Urabe A, Am J Gastroenterol. 2008 Dec;103(12):3005-10 |
| |
Evaluation of Helicobacter pylori vacA Genotypes in Iranian Patients with Peptic Ulcer Disease.
Salehi Z, Abadi AS, Ismail PB, Kqueen CY, Jelodar MH, Kamalidehghan B, Dig Dis Sci. 2008 Dec 12; |
| |
Helicobacter pylori cagA Status and Peptic Ulcer Disease in Iran.
Salehi Z, Jelodar MH, Rassa M, Ahaki M, Mollasalehi H, Mashayekhi F
Dig Dis Sci. 2008 Jul 10; |
| |
Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Study of Doxycycline, Co-Amoxiclav, and Omeprazole in Iranian Patients.
Taghavi SA, Jafari A, Eshraghian A
Dig Dis Sci. 2008 Jul 2; |
| |
| Supplementary evidence: |
| |
Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials.
Sachdeva A, Nagpal J, Eur J Gastroenterol Hepatol. 2009 Jan;21(1):45-53 |
| |
Review article: 'true' re-infection of Helicobacter pylori after successful eradication - worldwide annual rates, risk factors and clinical implications.
Zhang YY, Xia HH, Zhuang ZH, Zhong J, Aliment Pharmacol Ther. 2009 Jan 15;29(2):145-60 |
| |
Ethnicity, GORD, Barrett's oesophagus and Helicobacter pylori infection.
Rajendra S, Robertson IK, Gut. 2008 Dec;57(12):1738; author reply 1738-9 |
| |
Efficacy of the Standard Quadruple Therapy Versus Triple Therapies Containing Proton Pump Inhibitor Plus Amoxicillin and Clarithromycin or Amoxicillin-Clavulanic Acid and Metronidazole for Helicobacter pylori Eradication in Children.
Dehghani SM, Erjaee A, Imanieh MH, Haghighat M, Dig Dis Sci. 2008 Nov 14; |
| |
Lack of diagnostic utility of specific immunoglobulin M in Helicobacter pylori infection in children.
Serrano CA, Gonzáez CG, Rollan AR, Duarte I, Torres J, Peńa AJ, Harris PR, J Pediatr Gastroenterol Nutr. 2008 Nov;47(5):612-7 |
| |
Factors affecting physicians' practices related to Helicobacter pylori infection: effect of experience and mode of practice.
Yee YK, Cheung TK, Gu Q, Chan P, But D, Hung IF, Chan CK, Yuen MF, Wong BC, Digestion. 2008;78(2-3):77-81 |
| |
Prevalence and sociodemographic determinants of uninvestigated dyspepsia in the Czech Republic.
Rejchrt S, Koupil I, Kopácová M, Vorísek V, Seifert B, Pozler O, Zivný P, Douda T, Palicka V, Holcík J, Bures J, European Society for Primary Care Gastroenterology, Eur J Gastroenterol Hepatol. 2008 Sep;20(9):898-905 |